Low-end videoconferencing for vascular access device site assessment in homecare

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Vascular access devices (VAD) represent high technology and are used frequently in infant, pediatric, adult, and geriatric populations for vascular infusion of chemotherapy, immunotherapy, blood products, biologic response modifiers, nutrition support, analgesics, ionotropics, antibiotics, and other medications, as well as for extraction of pleural fluid from patients with chronic effusions and for treatment with dialysis. Increasingly, these devices are migrating to the home setting as they are used in chronic care and as insurance requirements reduce access to prolonged hospital stays. Surveillance of infections in high risk patients such as those with cancer, cardiac conditions, or post-trauma convalescence is essential to avoid adverse events and to offer early treatment. VAD site and blood stream infections are common VAD complications, occurring in up to 50% of home care patients, usually during days 4-25 after hospital discharge. Our literature search for reports of remote home monitoring for support of VAD patients and their caregivers found none. The use of videoconferencing technology to assess VAD sites in the post-discharge environment would significantly enhance patient safety, facilitate continuity of care, and meet the CommunicablE Disease Center's stated need for the development of surveillance systems to monitor infections in home care settings. Low-cost Internet- or telephone-based videoconferencing technology that could be deployed easily and used during risk periods would be highly beneficial to patients and increase the cost-effective use of homecare nursing personnel. We report criteria-based protocols for remote assessment of VAD status, for monitoring VAD care procedures employed in the home, and for conducting VAD-care teaching of patients and their caregivers. In addition, we report an initial evaluation of the ability to assess VAD status using low-end videoconferencing technologies.

Original languageEnglish (US)
Pages (from-to)135-138
Number of pages4
JournalJAVA - Journal of the Association for Vascular Access
Volume13
Issue number3
DOIs
StatePublished - Jan 1 2008

Fingerprint

Videoconferencing
Vascular Access Devices
Technology
Home Care Services
Caregivers
Infection
Costs and Cost Analysis
Heart Neoplasms
Continuity of Patient Care
Patient Safety
Insurance
Biological Products
Telephone
Geriatrics
Internet
Immunotherapy
Communicable Diseases
Blood Vessels
Analgesics
Dialysis

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Low-end videoconferencing for vascular access device site assessment in homecare. / Astapova, Elena V.; Stachura, Max E.; Chernecky, Cynthia; Rosenkoetter, Marlene M.

In: JAVA - Journal of the Association for Vascular Access, Vol. 13, No. 3, 01.01.2008, p. 135-138.

Research output: Contribution to journalArticle

@article{d1b667f6765f41cabca12471043a728b,
title = "Low-end videoconferencing for vascular access device site assessment in homecare",
abstract = "Vascular access devices (VAD) represent high technology and are used frequently in infant, pediatric, adult, and geriatric populations for vascular infusion of chemotherapy, immunotherapy, blood products, biologic response modifiers, nutrition support, analgesics, ionotropics, antibiotics, and other medications, as well as for extraction of pleural fluid from patients with chronic effusions and for treatment with dialysis. Increasingly, these devices are migrating to the home setting as they are used in chronic care and as insurance requirements reduce access to prolonged hospital stays. Surveillance of infections in high risk patients such as those with cancer, cardiac conditions, or post-trauma convalescence is essential to avoid adverse events and to offer early treatment. VAD site and blood stream infections are common VAD complications, occurring in up to 50{\%} of home care patients, usually during days 4-25 after hospital discharge. Our literature search for reports of remote home monitoring for support of VAD patients and their caregivers found none. The use of videoconferencing technology to assess VAD sites in the post-discharge environment would significantly enhance patient safety, facilitate continuity of care, and meet the CommunicablE Disease Center's stated need for the development of surveillance systems to monitor infections in home care settings. Low-cost Internet- or telephone-based videoconferencing technology that could be deployed easily and used during risk periods would be highly beneficial to patients and increase the cost-effective use of homecare nursing personnel. We report criteria-based protocols for remote assessment of VAD status, for monitoring VAD care procedures employed in the home, and for conducting VAD-care teaching of patients and their caregivers. In addition, we report an initial evaluation of the ability to assess VAD status using low-end videoconferencing technologies.",
author = "Astapova, {Elena V.} and Stachura, {Max E.} and Cynthia Chernecky and Rosenkoetter, {Marlene M.}",
year = "2008",
month = "1",
day = "1",
doi = "10.2309/java.13-3-6",
language = "English (US)",
volume = "13",
pages = "135--138",
journal = "JAVA - Journal of the Association for Vascular Access",
issn = "1552-8855",
publisher = "Association for Vascular Access",
number = "3",

}

TY - JOUR

T1 - Low-end videoconferencing for vascular access device site assessment in homecare

AU - Astapova, Elena V.

AU - Stachura, Max E.

AU - Chernecky, Cynthia

AU - Rosenkoetter, Marlene M.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Vascular access devices (VAD) represent high technology and are used frequently in infant, pediatric, adult, and geriatric populations for vascular infusion of chemotherapy, immunotherapy, blood products, biologic response modifiers, nutrition support, analgesics, ionotropics, antibiotics, and other medications, as well as for extraction of pleural fluid from patients with chronic effusions and for treatment with dialysis. Increasingly, these devices are migrating to the home setting as they are used in chronic care and as insurance requirements reduce access to prolonged hospital stays. Surveillance of infections in high risk patients such as those with cancer, cardiac conditions, or post-trauma convalescence is essential to avoid adverse events and to offer early treatment. VAD site and blood stream infections are common VAD complications, occurring in up to 50% of home care patients, usually during days 4-25 after hospital discharge. Our literature search for reports of remote home monitoring for support of VAD patients and their caregivers found none. The use of videoconferencing technology to assess VAD sites in the post-discharge environment would significantly enhance patient safety, facilitate continuity of care, and meet the CommunicablE Disease Center's stated need for the development of surveillance systems to monitor infections in home care settings. Low-cost Internet- or telephone-based videoconferencing technology that could be deployed easily and used during risk periods would be highly beneficial to patients and increase the cost-effective use of homecare nursing personnel. We report criteria-based protocols for remote assessment of VAD status, for monitoring VAD care procedures employed in the home, and for conducting VAD-care teaching of patients and their caregivers. In addition, we report an initial evaluation of the ability to assess VAD status using low-end videoconferencing technologies.

AB - Vascular access devices (VAD) represent high technology and are used frequently in infant, pediatric, adult, and geriatric populations for vascular infusion of chemotherapy, immunotherapy, blood products, biologic response modifiers, nutrition support, analgesics, ionotropics, antibiotics, and other medications, as well as for extraction of pleural fluid from patients with chronic effusions and for treatment with dialysis. Increasingly, these devices are migrating to the home setting as they are used in chronic care and as insurance requirements reduce access to prolonged hospital stays. Surveillance of infections in high risk patients such as those with cancer, cardiac conditions, or post-trauma convalescence is essential to avoid adverse events and to offer early treatment. VAD site and blood stream infections are common VAD complications, occurring in up to 50% of home care patients, usually during days 4-25 after hospital discharge. Our literature search for reports of remote home monitoring for support of VAD patients and their caregivers found none. The use of videoconferencing technology to assess VAD sites in the post-discharge environment would significantly enhance patient safety, facilitate continuity of care, and meet the CommunicablE Disease Center's stated need for the development of surveillance systems to monitor infections in home care settings. Low-cost Internet- or telephone-based videoconferencing technology that could be deployed easily and used during risk periods would be highly beneficial to patients and increase the cost-effective use of homecare nursing personnel. We report criteria-based protocols for remote assessment of VAD status, for monitoring VAD care procedures employed in the home, and for conducting VAD-care teaching of patients and their caregivers. In addition, we report an initial evaluation of the ability to assess VAD status using low-end videoconferencing technologies.

UR - http://www.scopus.com/inward/record.url?scp=53849107475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849107475&partnerID=8YFLogxK

U2 - 10.2309/java.13-3-6

DO - 10.2309/java.13-3-6

M3 - Article

AN - SCOPUS:53849107475

VL - 13

SP - 135

EP - 138

JO - JAVA - Journal of the Association for Vascular Access

JF - JAVA - Journal of the Association for Vascular Access

SN - 1552-8855

IS - 3

ER -